Colgate-Palmolive (CL) has had an intriguing journey in the recent years. An investment in the company five years ago would have yielded a 59% gain. Exhibiting strong performance, the company's stock has consistently outperformed its competitors. Large shares of CL have been acquired by multiple entities, indicating confidence in its performance. However, the 3-year Free Cash Flow (FCF) growth rate stands at -1.60%. On a brighter note, the company has been marked as a key player for the AI, growth, and low rates era by UBS. Also, it's suggested that the investors might be undervaluing CL by 39%. Despite short-term losses witnessed by institutional investors, the company presents a notable opportunity for EPS growth. The company has reported strong Q3 growth and revised its 2024 outlook. Q3 2024 earnings call highlighted strong organic sales growth. Impressively, the company boasts of strong institutional backing with 84-85% ownership. Despite recent insider shares sale, the company has beat Q3 earnings amid market share gains and margin expansion. The Q3 earnings topped estimates and revenue forecasts have been raised for 2024 on strong demand.
Colgate-Palmolive Company CL News Analytics from Thu, 28 Mar 2024 07:00:00 GMT to Sat, 30 Nov 2024 11:00:29 GMT -
Rating 7
- Innovation 1
- Information 9
- Rumor -4
